ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,052Medicare Part D Prescriptions Filled, Including Refills

Rank: 407 out of 5176

$858K Total Retail Price of All Prescriptions

Rank: 385 out of 5176

617 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 617 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

2% of this provider’s 617 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 9,555 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 813 687 1 1
LOSARTAN-HYDROCHLOROTHIAZIDE 462 380 2 35
METFORMIN HCL 447 354 3 7
OMEPRAZOLE 381 284 4 3
ZOLPIDEM TARTRATE 368 295 5 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 317 273 6 49
LOSARTAN POTASSIUM 258 216 7 14
AMLODIPINE BESYLATE 202 194 8 2
NEXIUM 196 150 9 16
CRESTOR 165 104 10 15
LEVOTHYROXINE SODIUM 161 119 11 4
DICLOFENAC SODIUM 157 113 12 160
MELOXICAM 148 101 13 53
LISINOPRIL 148 97 13 5
ATORVASTATIN CALCIUM 148 125 13 9
DIOVAN 148 126 13 19
DIOVAN HCT 146 132 17 39
FLUTICASONE PROPIONATE 142 103 18 38
FAMOTIDINE 138 111 19 58
METOPROLOL TARTRATE 126 107 20 6
SERTRALINE HCL 122 111 21 30
ALENDRONATE SODIUM 120 116 22 18
CICLOPIROX 116 96 23 279
DONEPEZIL HCL 114 108 24 28
GLYBURIDE-METFORMIN HCL 107 87 R 25 76
CLOTRIMAZOLE-BETAMETHASONE 106 68 26 94
ATENOLOL 106 102 26 12
METOPROLOL SUCCINATE 105 76 28 11
CARVEDILOL 98 89 29 24
MECLIZINE HCL 97 83 30 81
IBUPROFEN 97 56 30 72
TAMSULOSIN HCL 96 88 32 20
CLOBETASOL PROPIONATE 96 72 32 130
FENOFIBRATE 95 75 34 102
CLOPIDOGREL 90 75 35 26
PAROXETINE HCL 83 53 36 93
PLAVIX 81 76 37 29
NIFEDIPINE ER 80 72 38 48
GABAPENTIN 80 52 38 21
RANITIDINE HCL 79 75 40 36
TRAMADOL HCL-ACETAMINOPHEN 79 68 40 116
JANUMET 78 65 42 77
AMITIZA 75 67 43 197
NABUMETONE 75 60 43 217
ADVAIR DISKUS 73 43 45 32
NAMENDA 70 64 46 47
HYDROCHLOROTHIAZIDE 69 49 47 10
SINGULAIR 68 41 48 62
FUROSEMIDE 68 68 48 8
ACTOPLUS MET 64 49 50 268
LYRICA 61 51 51 133
PANTOPRAZOLE SODIUM 60 53 52 61
AMLODIPINE BESYLATE-BENAZEPRIL 60 48 52 55
AMMONIUM LACTATE 59 51 54 91
CELEBREX 58 49 55 80
NAPROXEN 58 24 55 95
JANUVIA 57 53 57 25
SPIRIVA 57 44 57 54
CLARITHROMYCIN 55 44 59 451
LANTUS SOLOSTAR 55 39 59 70
PREDNISONE 55 38 59 52
RAMIPRIL 54 34 62 50
SYMBICORT 53 45 63 120
AVODART 52 41 64 107
VENTOLIN HFA 51 37 65 64
TRIBENZOR 51 48 65 276
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.